New approaches for combined therapy of Hodgkin's lymphoma
https://doi.org/10.17650/1818-8346-2007-0-4-27-35
Abstract
Based on the treatment results of 819 patients we formulated new approaches for combined treatment of Hodgkin’s lymphoma stages I-IV. It was constructed a simplified prognostic model and developed new alternating chemotherapy regimens. We demonstrated the possibility of reducing the number of courses of chemotherapy to 4 in poor prognosis cases and the dispensability of achieving a complete effect after execution of medication period, emphasized the important role of a subradical programme, the expediency of zonal reduction offields, and the necessity of irradiating the whole volume of a lymphatic collector in the doses not greater than 30 Gy.
The above approaches offer prospects for treatment of Hodgkin’s lymphoma.
About the Authors
P. V. Dacenko
Russian Scientific Roentgen radiological Center, Ministry of Health Russian Federation
Russian Federation
Russian Federation
Moscow
G. A. Panshin
Russian Scientific Roentgen radiological Center, Ministry of Health Russian Federation
Russian Federation
Russian Federation
Moscow
V. M. Sotnikov
Russian Scientific Roentgen radiological Center, Ministry of Health Russian Federation
Russian Federation
Russian Federation
Moscow
Y. D. Melnik
Russian Scientific Roentgen radiological Center, Ministry of Health Russian Federation
Russian Federation
Russian Federation
Moscow
A. V. Ivashin
Russian Scientific Roentgen radiological Center, Ministry of Health Russian Federation
Russian Federation
Russian Federation
Moscow
P. N. Podolsky
Russian Scientific Roentgen radiological Center, Ministry of Health Russian Federation
Russian Federation
Russian Federation
Moscow
References
1. Ларионов Л.Ф. Лечение белокровия и лимфогранулематоза эмбихином. М.; 1951.
2. De Vita V.T., Serpick A., Carbone P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970;73:881—97.
3. Goldman A.J., Goldie J.H. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727—33.
4. Демина Е.А. Современная терапия первичных больных лимфомой Ходжкина. Автореф. дис. ... докт. мед. наук. М.; 2006.
5. Mauch P.V., Armitage J.D., Diehl V. et al. Hodgkin's disease. Philadelphia; 1999.
6. Wagner N.G., Barlett N.L. Lymphoma. In: The Washington manual of oncology. R. Govndan, M.A. Arguette (eds). Philadelphia, Lippincott Williams & Wilkins; 2002. p. 278—85.
7. Barlett N.L., Rosenberg S.A., Hoppe R.T. et al. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: A preliminary report. J Clin Oncol 1995;13:1080—8.
8. Diehl V., Franklin J., Hasenclever D. et al. BEACOPP: A new regimen for advanced Hodgkin's disease. Ann Oncol 1998;9(Suppl 5):67—71.
9. Diehl V. Современная терапия лимфомы Ходжкина. Конференция Malignant lymphoma 2, Lugano, 2005.
10. Peters V. A study of survival in Hodgkin's disease treated by irradiation. Am J Roentgenol 1950;63:299—311.
11. Wolf J., Diehl V. Hodgkin's disease -pathogenesis and therapy. Ther Umsch 1996;53(2):140—6.
12. Hoppe R.T. Hodgkin's disease: Second cancer after treatment Hodgkin's disease: Complications of therapy and excess mortality. Ann Oncol 1997; 8(Suppl 1):115.
13. Демина Е.А. Современное лечение первичных больных лимфомой Ходжкина. VII Рос. онкол. конгресс. М.; 2003. с. 103—8.
14. Даценко П.В. Сбалансированное сочетание лучевого и лекарственного компонентов при комплексном лечении лимфогранулематоза. Автореф. дис. . докт. мед. наук. М.; 2004.
15. Levis A., Gobbi P.G., Chisesi T. ABVD vs. Stanford vs. MOPP-EVP-CAD in advanced Hodgkin's lymphoma. Results of randomized trial. Ann Oncol 2002;13(Suppl 2):25.
16. Franklin J., Diehl V. Dose escalated BEACOPP chemotherapy regimen for advanced stage Hodgkin's disease: final analysis of the HD9 randomized trial of the GHSG. Ann Oncol 2002;13(Suppl 1):98—101.
17. Sieber M., Franklin J., Bredenfeld H. et al. Assessment of a 14 day variant of the BEACOPP regimen in advanced Hodgkin's Disease: results of pilot-study of the German Hodgkin's Lymphoma Study Group (GHSG). Ann Oncol 2002;13(Suppl 2):63.
18. Martinelli G., Cocorocchio E., Peccatori F. et al. ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis. Br J Haematol 2004;125(5):584—99.
19. Мельник Ю.Д. Новые программы лучевого и лекарственного лечения лимфогранулематоза. Автореф. дис. . канд. мед. наук. М.; 2006.
Review
For citations:
Dacenko P.V., Panshin G.A., Sotnikov V.M., Melnik Y.D., Ivashin A.V., Podolsky P.N. New approaches for combined therapy of Hodgkin's lymphoma. Oncohematology. 2007;(4):27-35. (In Russ.) https://doi.org/10.17650/1818-8346-2007-0-4-27-35
Views:
165
Email this article 